The World Health Organisation (WHO) estimates that breast cancer, the leading cause of cancer-related deaths among women, impacts approximately 2.1 million women each year.
Obesity is defined by body mass index more than 30. Body mass index is derived from your weight and height. Obesity is now rising across many countries in the world including India. It is said to have reached an epidemic proportion in our country with 5 % of the population being morbidly obese.
Back pain and age are two compatible words. Most people experiencing back pains range from the age of 35 to 55 years. Though it is painful and causes a lot of discomforts, in most cases it is not usually very serious...
बहुत कम लोगो को पता है की हमारे शरीर की इम्युनिटी या प्रतिरोध क्षमता ना केवल इन्फेक्शन बल्कि कैंसर से भी लड़ती है, शरीर में कैंसर बढ़ने से भी रोकती है। जब भी हमारे शरीर में कैंसर बनने लगता है तो इम्युनिटी प्रयास करती है की कैंसर ख़त्म हो जाय।
Boots UK in association with Macmillan Cancer Support and the NHS has launched a Palliative Care Service in its pharmacies to provide easy access to vital medicines and specialist pharmacist advice and support to patients.
As part of the new service, Boots has created a list of recommended medicines most used by terminally ill patients. It has committed to maintain stock of these medicines, or formulary, at over 2,000 of its pharmacies with an NHS contract.
To further support the launch of the new service, all 4,200 Boots Macmillan Information Pharmacists (BMIP) have received additional training on palliative care, including a range of cancer-related advice and side effects of medication.
Marc Donovan, chief pharmacist at Boots said: "Discussing end-of-life care is never easy, but it is very important. At this extremely difficult time for patients and their families and carers, ease of access to medicines and support can make a big difference.
Global pharmaceutical and biotechnology company AstraZeneca has signed an agreement with Scorpion Therapeutics to discover, develop and commercialize precision medicines against cancer proteins.
The collaboration, announced today (January 13), will focus on a class of proteins called transcription factors, which can regulate important cellular processes including cell growth and survival.
Many transcription factors have been identified earlier, but were considered 'undruggable' using conventional drug discovery approaches, the company said in a
statement.
Susan Galbraith, executive vice president, Oncology R&D, AstraZeneca, said: "Unlocking potentially transformative biology is pivotal for delivering the next wave of
cancer treatments.
"Scorpion's innovative platform is a strong strategic fit as we explore a range of new modalities across our broad drug discovery toolbox with promise to disrupt the activity of these highly-validated cancer targets."
French drugmaker Sanofi will make 30 of its treatments, including insulin, available on a not-for-profit basis in 40 lower-income countries in the first step
of its plan to increase access to its medicines worldwide.
The treatments will be provided under the new Impact brand, part of Sanofi's global health unit launched last year, which sits outside the commercial business.
The plan also includes the $25 million Impact fund, which will go towards supporting local start-up healthcare businesses and providing training on using the
medicines, Sanofi said.
"There's a lot of noise at the moment from different companies jumping into this space… but investing in entrepreneurship, in the ecosystem, is a new thing," said
Jon Fairest, who heads the global health unit.
The treatments available are on the World Health Organization's essential medicines list, and insulin in particular has been singled out by the UN agency as a
life-saving medicine for diabetics that is difficult to access in many lower-income countries, where the burden of disease is growing.
Morning friends,today i would like to stress on the importance of screening programmes for early detection of cervical cancer.Cervical cancer is perhaps the most common female genital tract cancer in the developing countries
MD Anderson Cancer Center and Ascentage Pharma entered into a five-year collaboration that aims to accelerate clinical development of novel apoptosis-targeted and tyrosine kinase inhibitor drug candidates for leukemia treatment.
Read the complete report Click on http://bit.ly/2NIzta5
NICE has recommended use of tucatinib as an option to treat HER2-positive breast cancer that has spread in people who have already tried 2 or more anti-HER2
treatments.
The move is set to benefit around 400 people with advanced breast cancer.
Tucatinib works by blocking a specific area of the HER2 gene in cancer cells, which stops the cells from growing and spreading. The medicine is taken as two 150 mg
tablets twice daily along with anti-cancer medicines trastuzumab and capecitabine.
Helen Knight, programme director in the NICE Centre for Health Technology Evaluation, said: "Unfortunately there is no cure for breast cancer that has spread to
other parts of the body. There is also a lack of additional anti‑HER2 treatments which can postpone the need for chemotherapy, especially for people whose cancer has spread to their brain because their treatment options are even more limited.
An oral drug combination by Novartis showed promise in treating a subgroup of patients suffering from a common childhood brain cancer in a trial.
In the mid-stage trial, 47 per cent of the patients that were given the two drugs Tafinlar and Mekinist saw their tumours shrink, far above a rate of 11 per cent
in a comparative group of participants on standard chemotherapy, the drugmaker said on Monday, June 6.
The participants, aged one to 17 years, were suffering from low-grade gliomas (LGG), the most common childhood brain cancer.
The trial only included those who were found to have a mutation known as BRAF V600, a genetic contributor in about 15 per cent to 20 per cent of paediatric LGG cases.
Among further results of the trial with 110 participants, the median time without disease progression was 20.1 months for those given the Novartis drug combo,
compared to 7.4 months on chemotherapy.
The new oral treatment candidate also caused less severe side effects than burdensome chemotherapy.
Yesterday during my outdoor posting i attended an elderly individual presenting with advanced features of
stomach cancer
.He was in a lot of anguish and pain.
Hey Dear Check Out Our Online Shopping store in all Over Pakistan.As Seen as On Tv Products Like as Health Beauty,Fitness,Homeware,Kitchenware,And Other Electronic Products in Pakistan Check Out Now| www.openTeleshop.Com
https://www.mymedistore.com/product/cimivir-400-mg/ Buy Cimivir 400 mg Online - Order Cheapest Cimivir 400 mg from Mymedistore- your most reliable online pharmacy. Avail best price in USA, by your doorsteps.
The King's condition is "benign" and he will be treated in the hospital next week for a "corrective procedure", Buckingham Palace said a statement released
on Wednesday.
"In common with thousands of men each year, the King has sought treatment for an enlarged prostate," the Palace said.
Because of the upcoming surgery, Charles had to postpone all meetings and events planned for this week.
The Palace informed that the King's public engagements will be "postponed for a short period of recuperation."
Charles, 75, wanted to share the details of his diagnosis to encourage more men who may be experiencing symptoms to get their conditions checked.
"Anything is possible with focused strength, resilience and determination" said Bhavin Shah, Financial Director at Sigma Pharmaceuticals plc, after
completing the annual London Marathon.
Shah donned his running gear and completed the 26.2 mile route in a commendable time of 5 hours and 33 minutes, all in support of 'Team George', a cause
initiated by his close friend, Jonathan Bracey, who is the EVP of corporate development at Tanner Pharma Group.
Bracey started the crowdfunding initiative last year after his 2-year-old son George was diagnosed with a rare cancer (rhabdomyosarcoma) on his liver/bile duct.
Sigma Pharmaceuticals directors and staff have played a vital part in helping raise over £52,000 over the last 6 months for 'Team George', which included the
London Marathon Charity run on Sunday 21 April 2024. The funds will be donated to four charities that have been instrumental in George's path to overcoming
cancer - Rays of Sunshine ward at Kings College Hospital Charity, St Mary's Hospital, Alice's Arc and Great Ormond Street Hospital.
For over three months, Shah had been training himself physically and mentally for the marathon run to support his friend's initiative. He joined Bracey in the
marathon, along with more than 50,000 other competitors.
Adding to the growing evidence of global medicine shortages, a new study has revealed that the European generic medicines market is "not in shape" to help
Europe meet its public health priorities.
In the past decade, the rate of generic medicines withdrawals has risen by 12 per cent, while there has been a three per cent decrease in the launch of generic
products, as per Teva Pharmaceuticals' recent analysis of IQVIA data.
Within the mental therapeutic area, seven per cent of generic products disappeared between 2013 and 2023, while there was a seven per cent decrease in the
availability of generic cancer medicines in just six years (2017-2022).
These medicines were listed on the Union List of Critical Medicines to help avoid potential shortages, as the European Commission (EC) said this could cause
"significant harm to patients and pose important challenges to health systems."
While mature generic products constitute the majority of the List, they remain susceptible to withdrawals, despite containing products crucial for safeguarding
Europe's public health, the Teva analysis report noted.
Since 2013, the number of generic products for the treatment of schizophrenia and bipolar disorder has declined by 25 per cent, with Hungary and Bulgaria
experiencing the biggest loss at 83 per cent and 58 per cent respectively.
Regular health screenings are an essential part of maintaining wellness, and one vital test for women is the Pap smear. Known for its role in early
detection of cervical cancer, the Pap smear is a simple yet powerful tool that can potentially save lives. In this blog, we will explore the significance of Pap
smears, what the procedure involves, and how often you should get tested.
The Importance of Regular Local Screenings
Staying on top of your health requires vigilance, and regular local screenings play an indispensable role in this effort. Local screenings, like Pap smears, are
essential in detecting potential health issues at their earliest stages, making treatments more effective and improving outcomes.
By participating in these routine checks, you not only safeguard your health but also contribute to broader public health efforts by identifying and addressing
potential outbreaks or health trends within the community. Whether that's HPV and Pap tests in Singapore or a mammogram in the US, local screenings are crucial
for maintaining overall wellness. This is especially true for Pap smears, as they play a significant role in detecting and preventing cervical cancer.